TNX-102 SL has the potential to be the first member of a new class of analgesic drugs for fibromyalgia and the first new drug ...

Navenibart is a monoclonal antibody commercialized by Astria Therapeutics, with a leading Phase II program in Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency).

"This is an exciting time to be joining Tonix as it prepares to receive an FDA decision on its NDA for TNX-102 SL for the ...

Overview: Pharming Group N.V. is a biopharmaceutical company that develops and commercializes protein replacement therapies and precision medicines for rare diseases across the United States ...

Berinert是一种血浆来源的C1酯酶抑制剂（人），用于治疗成人和儿童遗传性血管性水肿（HAE）发作的急性腹部、面部或喉部发作。 C1 酯酶抑制剂（人）500 IU；每瓶；重构后用于静脉注射的冻干粉末；不含防腐剂。 【药理类别】 C1 抑制剂。 平台声明：该文观点仅 ...